UBS Lux Equity Fund Biotech USD vs T. Rowe Price US Large Cap Growth Equity Fund A USD

UBS Lux Equity Fund Biotech USD vs T. Rowe Price US Large Cap Growth Equity Fund A USD

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Security

    T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Fee

    1.59%

  • ISIN

    LU0174119429

  • Holdings

    10

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with T. Rowe Price US Large Cap Growth Equity Fund A USD, we have 20 holdings where Apple is the largest holding (9.72), followed by Microsoft (9.66) and Nvidia (8.48).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and T. Rowe Price US Large Cap Growth Equity Fund A USD.

UBS Lux Equity Fund Biotech USD T. Rowe Price US Large Cap Growth Equity Fund A USD
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Apple Inc
USA
9.72 %
2. Vertex Pharmaceuticals Inc
9.35 %
2. Microsoft Corp
USA
9.66 %
3. Moderna Inc
9.21 %
3. Nvidia Corp
USA
8.48 %
4. Alnylam Pharmaceuticals Inc
6.96 %
4. Amazon.com Inc
USA
7.9 %
5. AbbVie Inc
USA
5.53 %
5. Alphabet Inc Class A
USA
4.7 %
6. Gilead Sciences Inc
USA
4.66 %
6. Meta Platforms A
USA
4.66 %
7. Amgen Inc
4.3 %
7. Mastercard Inc
USA
3.72 %
8. BioNTech SE
4.13 %
8. Intuit Inc
3.31 %
9. Karuna Therapeutics Inc
3.75 %
9. ServiceNow Inc
USA
2.9 %
10. Royalty Pharma Plc
3.37 %
10. Visa Inc
USA
2.77 %

The list of fund holdings was last updated on June 6, 2025.